PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
3.12%
Revenue growth similar to NXPI's 3.21%. Walter Schloss would see if both companies share industry tailwinds.
223.36%
Gross profit growth above 1.5x NXPI's 0.13%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
31.15%
Positive EBIT growth while NXPI is negative. John Neff might see a substantial edge in operational management.
31.15%
Positive operating income growth while NXPI is negative. John Neff might view this as a competitive edge in operations.
24.78%
Positive net income growth while NXPI is negative. John Neff might see a big relative performance advantage.
37.80%
Positive EPS growth while NXPI is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
37.80%
Positive diluted EPS growth while NXPI is negative. John Neff might view this as a strong relative advantage in controlling dilution.
14.90%
Slight or no buybacks while NXPI is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
14.90%
Slight or no buyback while NXPI is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
-75.13%
Dividend reduction while NXPI stands at 0.12%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
35000.00%
OCF growth above 1.5x NXPI's 37.88%. David Dodd would confirm a clear edge in underlying cash generation.
321.90%
FCF growth above 1.5x NXPI's 94.26%. David Dodd would verify if the firm’s strategic investments yield superior returns.
28.18%
10Y revenue/share CAGR under 50% of NXPI's 79.10%. Michael Burry would suspect a lasting competitive disadvantage.
17.88%
5Y revenue/share CAGR under 50% of NXPI's 77.31%. Michael Burry would suspect a significant competitive gap or product weakness.
-2.29%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-82.91%
Negative 10Y net income/share CAGR while NXPI is at 36.73%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-387.17%
Negative 5Y net income/share CAGR while NXPI is 328.95%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-184.17%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
21.11%
Below 50% of NXPI's 1254.96%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
1.73%
Below 50% of NXPI's 18.89%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
7.09%
Below 50% of NXPI's 42.98%. Michael Burry suspects a serious short-term disadvantage in building book value.
-15.75%
Cut dividends over 10 years while NXPI stands at 0.00%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
-15.75%
Negative 5Y dividend/share CAGR while NXPI stands at 169.49%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
56.02%
3Y dividend/share CAGR above 1.5x NXPI's 20.43%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
-12.39%
Firm’s AR is declining while NXPI shows 1.04%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-5.12%
Inventory is declining while NXPI stands at 0.47%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-1.55%
Negative asset growth while NXPI invests at 0.28%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-20.60%
We have a declining book value while NXPI shows 3.20%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-4.73%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
0.90%
We expand SG&A while NXPI cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.